p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer. [electronic resource]
Producer: 19981202Description: 823-30 p. digitalISSN:- 0893-3952
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- metabolism
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Drug Resistance, Neoplasm
- Female
- Humans
- Immunohistochemistry
- Middle Aged
- Prognosis
- Proportional Hazards Models
- Receptor, ErbB-2 -- metabolism
- Retrospective Studies
- Survival Rate
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.